Linda Kelley

1.4k total citations
40 papers, 1.1k citations indexed

About

Linda Kelley is a scholar working on Oncology, Molecular Biology and Hematology. According to data from OpenAlex, Linda Kelley has authored 40 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 13 papers in Molecular Biology and 13 papers in Hematology. Recurrent topics in Linda Kelley's work include Hematopoietic Stem Cell Transplantation (11 papers), CAR-T cell therapy research (10 papers) and Immunotherapy and Immune Responses (6 papers). Linda Kelley is often cited by papers focused on Hematopoietic Stem Cell Transplantation (11 papers), CAR-T cell therapy research (10 papers) and Immunotherapy and Immune Responses (6 papers). Linda Kelley collaborates with scholars based in United States, Poland and Australia. Linda Kelley's co-authors include Maurice C. Bondurant, Mark J. Koury, Cheryl A. Cox, Shari Pilon‐Thomas, Lou Ann Barnett, Igor Matushansky, Arthur I. Skoultchi, Geoffrey G. Hicks, H. Earl Ruley and Michael Boyer and has published in prestigious journals such as Journal of Biological Chemistry, Blood and PLoS ONE.

In The Last Decade

Linda Kelley

37 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Linda Kelley United States 20 438 372 268 178 135 40 1.1k
Antonella Conforti Italy 17 356 0.8× 208 0.6× 270 1.0× 376 2.1× 151 1.1× 31 1.0k
Tracy Heng Australia 14 344 0.8× 305 0.8× 828 3.1× 210 1.2× 191 1.4× 21 1.4k
Christopher Siatskas Australia 20 482 1.1× 166 0.4× 343 1.3× 407 2.3× 58 0.4× 39 1.3k
Cristina Eguizábal Spain 20 679 1.6× 266 0.7× 317 1.2× 66 0.4× 47 0.3× 51 1.3k
Lies Geboes Belgium 13 325 0.7× 235 0.6× 607 2.3× 146 0.8× 103 0.8× 14 1.1k
David George United States 20 697 1.6× 101 0.3× 160 0.6× 189 1.1× 176 1.3× 28 1.2k
Peggy Kirstetter France 12 854 1.9× 178 0.5× 602 2.2× 142 0.8× 373 2.8× 15 1.5k
Darja Karpova United States 15 520 1.2× 261 0.7× 290 1.1× 82 0.5× 227 1.7× 27 956
Annabella Procoli Italy 14 271 0.6× 368 1.0× 231 0.9× 87 0.5× 88 0.7× 19 826
Yingjun Su China 23 644 1.5× 280 0.8× 247 0.9× 125 0.7× 25 0.2× 63 1.5k

Countries citing papers authored by Linda Kelley

Since Specialization
Citations

This map shows the geographic impact of Linda Kelley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linda Kelley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linda Kelley more than expected).

Fields of papers citing papers by Linda Kelley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linda Kelley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linda Kelley. The network helps show where Linda Kelley may publish in the future.

Co-authorship network of co-authors of Linda Kelley

This figure shows the co-authorship network connecting the top 25 collaborators of Linda Kelley. A scholar is included among the top collaborators of Linda Kelley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linda Kelley. Linda Kelley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Freeman, Ciara L., Meghan Menges, Jeffrey Edelman, et al.. (2023). Survivin Dendritic Cell Vaccine Safely Induces Immune Responses and Is Associated with Durable Disease Control after Autologous Transplant in Patients with Myeloma. Clinical Cancer Research. 29(22). 4575–4585. 8 indexed citations
3.
Gee, Adrian P., Cheryl A. Cox, Joshua M. Hare, et al.. (2022). Assessment of the LOVO device for final harvest of novel cell therapies: a Production Assistance for Cellular Therapies multi-center study. Cytotherapy. 24(7). 691–698. 6 indexed citations
4.
Landin, Ana Marie, et al.. (2021). Expansion and Enrichment of Gamma-Delta (γδ) T Cells from Apheresed Human Product. Journal of Visualized Experiments. 2 indexed citations
5.
Landin, Ana Marie, Cheryl A. Cox, Bin Yu, et al.. (2021). Expansion and Enrichment of Gamma-Delta (γδ) T Cells from Apheresed Human Product. Journal of Visualized Experiments. 13 indexed citations
6.
Thibodeaux, Suzanne R., David H. McKenna, Zbigniew M. Szczepiorkowski, et al.. (2020). A multicenter evaluation of heterogeneity in cellular therapy processing laboratory procedure times to assess workload capacity. Transfusion. 60(8). 1811–1820. 3 indexed citations
7.
Shrestha, Bishwas, Yongliang Zhang, Bin Yu, et al.. (2019). Generation of Antitumor T Cells For Adoptive Cell Therapy With Artificial Antigen Presenting Cells. Journal of Immunotherapy. 43(3). 79–88. 20 indexed citations
8.
Creelan, Ben, Jamie K. Teer, Eric M. Toloza, et al.. (2018). OA05.03 Safety and Clinical Activity of Adoptive Cell Transfer Using Tumor Infiltrating Lymphocytes (TIL) Combined with Nivolumab in NSCLC. Journal of Thoracic Oncology. 13(10). S330–S331. 6 indexed citations
9.
Mullinax, John E., MacLean Hall, Sangeetha Prabhakaran, et al.. (2018). Combination of Ipilimumab and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma. Frontiers in Oncology. 8. 44–44. 75 indexed citations
10.
Hopewell, Emily, Cheryl A. Cox, Shari Pilon‐Thomas, & Linda Kelley. (2018). Tumor-infiltrating lymphocytes: Streamlining a complex manufacturing process. Cytotherapy. 21(3). 307–314. 46 indexed citations
11.
Gray, Jhanelle E., Alberto Chiappori, Tawee Tanvetyanon, et al.. (2018). A phase I/randomized phase II study of GM.CD40L vaccine in combination with CCL21 in patients with advanced lung adenocarcinoma. Cancer Immunology Immunotherapy. 67(12). 1853–1862. 29 indexed citations
12.
Janssen, William E., et al.. (2018). An automated method of enrichment of lymphocytes from apheresis products for cellular engineering. Cytotherapy. 20(5). S70–S70.
13.
Morris, Julie, et al.. (2013). Serum-converted platelet lysate can substitute for fetal bovine serum in human mesenchymal stromal cell cultures. Cytotherapy. 15(12). 1458–1468. 88 indexed citations
14.
Lepore, Angelo C., John O’Donnell, Timothy L. Williams, et al.. (2011). Human Glial-Restricted Progenitor Transplantation into Cervical Spinal Cord of the SOD1G93A Mouse Model of ALS. PLoS ONE. 6(10). e25968–e25968. 87 indexed citations
15.
16.
Prasher, Joanna M., Kojo S.J. Elenitoba‐Johnson, & Linda Kelley. (2001). Loss of p53 tumor suppressor function is required for in vivo progression of Friend erythroleukemia. Oncogene. 20(23). 2946–2955. 10 indexed citations
17.
18.
Kelley, Linda, Geoffrey G. Hicks, Joanna M. Prasher, et al.. (1998). Endogenous p53 regulation and function in early stage Friend virus-induced tumor progression differs from that following DNA damage. Oncogene. 17(9). 1119–1130. 12 indexed citations
19.
20.
Kelley, Linda, P F Blackmore, Stanley E. Gräber, & Samantha Stewart. (1990). Agents that raise cAMP in human T lymphocytes release an intracellular pool of calcium in the absence of inositol phosphate production.. Journal of Biological Chemistry. 265(29). 17657–17664. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Antonella Conforti Breakdown of academic impact, for papers by Tracy Heng Breakdown of academic impact, for papers by Christopher Siatskas Breakdown of academic impact, for papers by Cristina Eguizábal Breakdown of academic impact, for papers by Lies Geboes Breakdown of academic impact, for papers by David George Breakdown of academic impact, for papers by Peggy Kirstetter Breakdown of academic impact, for papers by Darja Karpova Breakdown of academic impact, for papers by Annabella Procoli Breakdown of academic impact, for papers by Yingjun Su
Rankless by CCL
2026